Transgene Biotek Limited
BSE: TRABI.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Koteswara Rao Kanuru
- Headquarters
- Hyderabad, India
- IPO year
- 2001
- Market cap
- ₹234.9M
- Website
- http://www.transgenebiotek.com
Loading TRABI…
Loading profile data…Frequently asked questions about TRABI
What does Transgene Biotek Limited (TRABI.BO) do?
Transgene Biotek Ltd. is a biotechnology company, which manufactures and sells diagnostic kits. It involves in the production and oral formulation of different proteins using TrabiORAL technology. The firm's products portfolio includes TrabiDHA, Tacrolimus, and Orlistat. The company was founded by K. Koteswara Rao in 1991 and is headquartered in...
Where does TRABI.BO trade?
Transgene Biotek Limited (TRABI.BO) trades on the Bombay Stock Exchange.
What sector is TRABI.BO in?
Transgene Biotek Limited (TRABI.BO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Transgene Biotek Limited?
Koteswara Rao Kanuru is the chief executive officer of Transgene Biotek Limited (TRABI.BO).
Where is Transgene Biotek Limited headquartered?
Transgene Biotek Limited is headquartered in India.
Does TRABI.BO pay a dividend?
Transgene Biotek Limited (TRABI.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TRABI.BO go public?
Transgene Biotek Limited (TRABI.BO) completed its initial public offering in 2001.